suprefact 5.5mg/5.5ml solution for injection vials
neon healthcare ltd - buserelin acetate - solution for injection - 1mg/1ml
suprefact 100micrograms/dose nasal spray
neon healthcare ltd - buserelin acetate - spray - 100microgram/1dose
suprefact injection solution
sanofi-aventis (malaysia) sdn. bhd. - buserelin acetate -
suprefact 1 mg/ml 2 vials 5.5 ml
suprefact nasal 100 mcg/pulsació 2 nebul nasals
suprefact
sanofi-aventis new zealand limited - buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin - solution for injection - 1 mg/ml - active: buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin excipient: benzyl alcohol monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - for the treatment of endometriosis not primarily requiring surgical treatment. pituitary desensitisation in preparation for ovulation induction regimens using gonadotrophins.
suprefact solution
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 100mcg - buserelin (buserelin acetate) 100mcg - antineoplastic agents
suprefact solution
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 1mg - buserelin (buserelin acetate) 1mg - antineoplastic agents
suprefact depot 6.3 mg implant
sanofi-aventis ireland limited - buserelin - implant - 6.3 milligram
suprefact depot 6.3 mg implant 6.3 milligram implant
sanofi-aventis ireland limited t/a sanofi - buserelin - implant - 6.3 milligram